We have recently shown that systemic delivery of autoimmune disease-relevant pMHCII-NPs expands cognate TFH cells and triggers the transdifferentiation of these TFH cells into disease-suppressing Foxp3– TR1-like cells (7, 9–13). Here, FOXP3 is linked to autoimmune disease.